Commentary: Choice of prosthesis in the hemodialysis patient: Everything old is new again

Valvular heart disease is particularly prevalent in the hemodialysis population, affecting 19.1% of end-stage renal disease (ESRD) patients, most commonly involving the aortic valve and usually presenting as aortic stenosis.1 Valve selection in this population is particularly challenging. Mechanical valves are less vulnerable to the accelerated structural valve deterioration (SVD) observed in the bioprostheses of ESRD patients and were, in fact, the recommendation of the 1998 American College of Cardiology/American Heart Association Guidelines.

Source: Seminars in Thoracic and Cardiovascular Surgery - September 27, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Takuya Ogami, Paul Kurlansky Source Type: research